Cite
HARVARD Citation
Martynova, A. et al. (2019). Aggressive systemic mastocytosis: midostaurin is safe, feasible and associated with durable response post‐haploidentical allogeneic stem cell transplant. British journal of haematology. pp. e139-e141. [Online].